A detailed history of Crossmark Global Holdings, Inc. transactions in Amedisys Inc stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 2,514 shares of AMED stock, worth $213,614. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,514
Holding current value
$213,614
% of portfolio
0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$96.5 - $98.45 $242,601 - $247,503
2,514 New
2,514 $243,000
Q1 2024

May 13, 2024

SELL
$92.15 - $95.24 $9,122 - $9,428
-99 Reduced 3.92%
2,427 $223,000
Q4 2023

Feb 13, 2024

BUY
$91.15 - $95.89 $2,552 - $2,684
28 Added 1.12%
2,526 $240,000
Q3 2023

Nov 08, 2023

SELL
$89.84 - $94.08 $808 - $846
-9 Reduced 0.36%
2,498 $231,000
Q2 2023

Jul 31, 2023

SELL
$73.99 - $92.6 $26,266 - $32,873
-355 Reduced 12.4%
2,507 $227,000
Q1 2023

May 12, 2023

BUY
$69.79 - $100.33 $26,031 - $37,423
373 Added 14.99%
2,862 $210,000
Q4 2022

Jan 19, 2023

SELL
$80.12 - $105.34 $21,151 - $27,809
-264 Reduced 9.59%
2,489 $208,000
Q3 2022

Nov 01, 2022

BUY
$96.79 - $131.14 $2,322 - $3,147
24 Added 0.88%
2,753 $266,000
Q2 2022

Jul 29, 2022

SELL
$105.12 - $173.85 $6,307 - $10,431
-60 Reduced 2.15%
2,729 $287,000
Q1 2022

May 11, 2022

SELL
$124.79 - $178.09 $16,222 - $23,151
-130 Reduced 4.45%
2,789 $480,000
Q4 2021

Jan 10, 2022

SELL
$136.32 - $184.41 $137,683 - $186,254
-1,010 Reduced 25.71%
2,919 $473,000
Q3 2021

Oct 21, 2021

SELL
$149.1 - $270.32 $2.12 Million - $3.84 Million
-14,190 Reduced 78.32%
3,929 $586,000
Q3 2021

Oct 13, 2021

BUY
$149.1 - $270.32 $2.09 Million - $3.8 Million
14,050 Added 345.29%
18,119 $250,000
Q2 2021

Jul 21, 2021

SELL
$238.97 - $288.5 $66,911 - $80,780
-280 Reduced 6.44%
4,069 $997,000
Q1 2021

Apr 15, 2021

BUY
$236.62 - $314.16 $23,662 - $31,416
100 Added 2.35%
4,349 $1.15 Million
Q4 2020

Jan 14, 2021

BUY
$231.3 - $293.33 $127,215 - $161,331
550 Added 14.87%
4,249 $1.25 Million
Q3 2020

Oct 08, 2020

SELL
$199.22 - $248.1 $7,968 - $9,924
-40 Reduced 1.07%
3,699 $875,000
Q2 2020

Aug 14, 2020

BUY
$169.77 - $213.81 $71,303 - $89,800
420 Added 12.65%
3,739 $742,000
Q1 2020

Apr 28, 2020

SELL
$137.21 - $202.02 $15,093 - $22,222
-110 Reduced 3.21%
3,319 $609,000
Q4 2019

Feb 06, 2020

SELL
$122.85 - $167.13 $201,474 - $274,093
-1,640 Reduced 32.35%
3,429 $572,000
Q3 2019

Oct 09, 2019

SELL
$117.97 - $137.89 $2,359 - $2,757
-20 Reduced 0.39%
5,069 $664,000
Q2 2019

Jul 09, 2019

SELL
$108.08 - $129.67 $56,201 - $67,428
-520 Reduced 9.27%
5,089 $618,000
Q1 2019

May 02, 2019

BUY
$110.76 - $138.73 $1,107 - $1,387
10 Added 0.18%
5,609 $691,000
Q4 2018

Jan 31, 2019

SELL
$98.2 - $140.23 $342,718 - $489,402
-3,490 Reduced 38.4%
5,599 $656,000
Q3 2018

Nov 08, 2018

SELL
$87.74 - $125.01 $38,605 - $55,004
-440 Reduced 4.62%
9,089 $1.14 Million
Q2 2018

Jul 31, 2018

BUY
$60.06 - $87.93 $24,024 - $35,172
400 Added 4.38%
9,529 $814,000
Q1 2018

Apr 16, 2018

SELL
$50.51 - $62.74 $40,408 - $50,192
-800 Reduced 8.06%
9,129 $551,000
Q4 2017

Feb 05, 2018

BUY
$46.45 - $58.49 $177,903 - $224,016
3,830 Added 62.8%
9,929 $523,000
Q3 2016

Oct 25, 2017

BUY
N/A
6,099
6,099 $341,000

Others Institutions Holding AMED

About AMEDISYS INC


  • Ticker AMED
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 32,492,000
  • Market Cap $2.76B
  • Description
  • Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal...
More about AMED
Track This Portfolio

Track Crossmark Global Holdings, Inc. Portfolio

Follow Crossmark Global Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.